Paraoxonase 1 mass (PON1) and microvascular complications in type 2 diabetes (DM)

被引：0
|
作者：
Hanley, Anthony J.
Zinman, Bernard
Maguire, Graham
Mamakeesick, Mary
Harris, Stewart B.
Hegele, Robert
Retnakaran, Ravi
Klein, Ronald
Connelly, Phillip W.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A213 / A213
页数：1
相关论文
共 50 条
  • [1] Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation
    Shokri, Yasaman
    Variji, Atena
    Nosrati, Mani
    Khonakdar-Tarsi, Abbas
    Kianmehr, Anvarsadat
    Kashi, Zahra
    Bahar, Adele
    Bagheri, Abouzar
    Mahrooz, Abdolkarim
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 161
  • [2] Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
    Rosta, Valentina
    Trentini, Alessandro
    Passaro, Angelina
    Zuliani, Giovanni
    Sanz, Juana Maria
    Bosi, Cristina
    Bonaccorsi, Gloria
    Bellini, Tiziana
    Cervellati, Carlo
    [J]. ANTIOXIDANTS, 2020, 9 (08) : 1 - 12
  • [3] Serum Paraoxonase Levels and PON1(192) Polymorphism in Type 2 Diabetes Mellitus Patients
    Gokcen, Sanem
    Cengiz, Mujgan
    Ozaydin, Ahmet
    [J]. GAZI MEDICAL JOURNAL, 2013, 24 (03): : 70 - 73
  • [4] GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
    Ginsberg, Gary
    Neafsey, Patricia
    Hattis, Dale
    Guyton, Kathryn Z.
    Johns, Douglas O.
    Sonawane, Babasaheb
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 473 - 507
  • [5] Modulation of paraoxonase (PON1) activity
    Costa, LG
    Vitalone, A
    Cole, TB
    Furlong, CE
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) : 541 - 550
  • [6] Paraoxonase (PON1) and organophosphate toxicity
    Costa, L. G.
    Cole, T. B.
    Jansen, K. L.
    Furlong, C. E.
    [J]. PARAOXNASES: THEIR ROLE IN DISEASE DEVELOPMENT AND XENOBIOTIC METABOLISM, 2008, 6 : 209 - +
  • [7] Paraoxonase gene polymorphism (PON1 192) is associated with endothelial function in patients with type 2 diabetes
    Irace, C.
    Cortese, C.
    Dell'Aquila, F.
    Liberatoscioli, L.
    Mannucci, L.
    Federici, G.
    Gnasso, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 353 - 353
  • [8] Paraoxonase gene polymorphism (PON1 192) is associated with endothelial function in subjects with type 2 diabetes
    Cortese, C
    Liberatoscioli, L
    Mannucci, L
    Federici, G
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S83 - S83
  • [9] Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
    Qujeq D.
    Mahrooz A.
    Alizadeh A.
    Masoumi P.
    Annemohammadzadeh S.
    Boorank R.
    [J]. Journal of Diabetes & Metabolic Disorders, 2018, 17 (1): : 1 - 10
  • [10] Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice
    Rozenberg, O
    Shih, DM
    Aviram, M
    [J]. ATHEROSCLEROSIS, 2005, 181 (01) : 9 - 18
12345